Head-to-head · WeighScore
Ondra Health vs System Labs
The verdict
Ondra Health takes it — 86.8/100 to 68.4/100.
Ondra Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lowest semaglutide sticker on the board ($93) paired with some brand-name access and LegitScript verification.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ondra Health | System Labs |
|---|---|---|
| WeighScore | 86.8/100 | 68.4/100 |
| Grade | B | C |
| Scorecard rank | #10 | #89 |
| Semaglutide | $93/mo | Not offered |
| Tirzepatide | $166/mo | $179/mo flat at every dose ($99 first month only, then $179) |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #10 · B
Strengths
- Lowest listed semaglutide price ($93/mo)
- Some brand-name access
- LegitScript-verified, all 50 states
Where it loses points
- Tirzepatide steps up to $166/mo
- Labs/monitoring detail not published
- Compounded-first
Graded #89 · C
Strengths
- A flat $179/mo month-to-month rate at every dose, stated in the company's own FAQ as "a flat $179/mo with no hidden fees" — there is no prepay rung to buy down to it, no membership fee and no per-visit charge on top
- Three named physicians with checkable credentials sit on the medical board — Dr Marc Gruner (sports medicine, trained at Mayo Clinic), Dr Jonathan Hinds (board-certified emergency medicine, trained at Rutgers) and Dr Gregory Tennant (fellowship-trained orthopaedic trauma surgeon, trained at Vanderbilt) — where most of this board names nobody at all
- Free two-day temperature-controlled shipping with injection supplies included, automatic refills on your own schedule, and pause or cancel yourself from the dashboard
- The lander carries its own bolded disclosure that the compounded product is not FDA-approved, rather than leaving a reader to work that out afterwards
Where it loses points
- One molecule only — the product is a compounded GLP-1/GIP built on tirzepatide, and there is no semaglutide option at any price
- The advertised "$99" is a first-month introductory rate, labelled "/first mo." on the page itself; from month two the bill is $179, so the first charge is not the standing cost
- Weekly subcutaneous injection only — no oral or sublingual route, and no brand-name Zepbound or Mounjaro lane
- The states served are published nowhere; one board physician is described as licensed in all 50, which is a fact about a clinician and not a statement of where the company can dispense
- The dispensing pharmacy is identified only as "a certified U.S. pharmacy" — never a facility, never a city, never a 503A or 503B designation
- No lab or monitoring programme is published — nothing states whether baseline or follow-up bloodwork is required, included in the price, or billed on top of it
- Compounded tirzepatide is not FDA-approved and is not a generic equivalent of Zepbound or Mounjaro
- The testimonials are first-name-and-age only, and several of them praise the NAD+ and glutathione lines rather than the GLP-1 programme, so they are no evidence about this product
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 508 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.